CO6280493A2 - Forma cristalina 1 de 2-((r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida - Google Patents

Forma cristalina 1 de 2-((r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida

Info

Publication number
CO6280493A2
CO6280493A2 CO10049261A CO10049261A CO6280493A2 CO 6280493 A2 CO6280493 A2 CO 6280493A2 CO 10049261 A CO10049261 A CO 10049261A CO 10049261 A CO10049261 A CO 10049261A CO 6280493 A2 CO6280493 A2 CO 6280493A2
Authority
CO
Colombia
Prior art keywords
benzimidazol
approximately
carboxamida
pirrolidin
methyl
Prior art date
Application number
CO10049261A
Other languages
English (en)
Spanish (es)
Inventor
Lawrence Kolaczkowski
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40210712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6280493(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO6280493A2 publication Critical patent/CO6280493A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO10049261A 2007-10-12 2010-04-27 Forma cristalina 1 de 2-((r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida CO6280493A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97964307P 2007-10-12 2007-10-12

Publications (1)

Publication Number Publication Date
CO6280493A2 true CO6280493A2 (es) 2011-05-20

Family

ID=40210712

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10049261A CO6280493A2 (es) 2007-10-12 2010-04-27 Forma cristalina 1 de 2-((r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida

Country Status (28)

Country Link
US (4) US8372987B2 (https=)
EP (2) EP2212327A1 (https=)
JP (4) JP2011500589A (https=)
KR (2) KR20100090769A (https=)
CN (2) CN101821270A (https=)
AU (1) AU2008310781B2 (https=)
BR (1) BRPI0816221A8 (https=)
CA (2) CA3006332A1 (https=)
CO (1) CO6280493A2 (https=)
CR (1) CR11368A (https=)
DK (1) DK2722046T3 (https=)
DO (1) DOP2010000099A (https=)
EC (1) ECSP10010150A (https=)
ES (1) ES2620299T3 (https=)
GT (1) GT201000080A (https=)
MX (1) MX350019B (https=)
MY (1) MY156691A (https=)
NZ (1) NZ583209A (https=)
PA (1) PA8798401A1 (https=)
PH (1) PH12012501636A1 (https=)
PL (1) PL2722046T3 (https=)
PT (1) PT2722046T (https=)
RU (2) RU2476434C2 (https=)
SG (1) SG185297A1 (https=)
TW (1) TWI422588B (https=)
UA (2) UA113277C2 (https=)
WO (1) WO2009049111A1 (https=)
ZA (1) ZA201002090B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY156691A (en) 2007-10-12 2016-03-15 Abbvie Bahamas Ltd 2-(r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline from 1
CA2696423A1 (en) 2007-10-12 2009-04-16 Guidong Zhu 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2
TW201702218A (zh) 2014-12-12 2017-01-16 美國杰克森實驗室 關於治療癌症、自體免疫疾病及神經退化性疾病之組合物及方法
CN105130961B (zh) * 2015-08-06 2018-02-16 苏州晶云药物科技有限公司 Abt‑888的晶型b及其制备方法和应用
CN106995436A (zh) * 2016-01-25 2017-08-01 重庆医药工业研究院有限责任公司 一种维利帕尼晶型a及其制备方法
US20190092756A1 (en) * 2016-03-09 2019-03-28 Crystal Pharmatech Co., Ltd. Crystalline form a of 2-[(2r)-2-methyl-2-pyrrolidyl]-1h-benzimidazole-7-carboxamide dihydrochloride and preparation method thereof
EP3275434B1 (en) 2016-07-27 2020-08-26 Sandoz Ag An extended release oral dosage form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1248869A2 (en) * 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
EP1298125A1 (en) * 2001-09-26 2003-04-02 Aventis Pharma S.A. Substituted benzimidazole compounds and their use for the treatment of cancer
TWI375673B (en) * 2005-04-11 2012-11-01 Abbott Lab 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
MY156691A (en) 2007-10-12 2016-03-15 Abbvie Bahamas Ltd 2-(r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline from 1
CA2696423A1 (en) * 2007-10-12 2009-04-16 Guidong Zhu 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2

Also Published As

Publication number Publication date
BRPI0816221A8 (pt) 2015-09-22
EP2212327A1 (en) 2010-08-04
JP2019001811A (ja) 2019-01-10
CA3006332A1 (en) 2009-04-16
CN101821270A (zh) 2010-09-01
US20140024838A1 (en) 2014-01-23
RU2010116397A (ru) 2011-11-20
NZ583209A (en) 2012-06-29
MX2010003772A (es) 2010-04-21
CN105367554A (zh) 2016-03-02
ECSP10010150A (es) 2010-06-29
JP2011500589A (ja) 2011-01-06
SG185297A1 (en) 2012-11-29
EP2722046B1 (en) 2016-12-21
RU2012147692A (ru) 2014-05-20
PL2722046T3 (pl) 2017-06-30
US20130123317A1 (en) 2013-05-16
US9580410B2 (en) 2017-02-28
US8372987B2 (en) 2013-02-12
ZA201002090B (en) 2011-11-30
PT2722046T (pt) 2017-03-15
WO2009049111A1 (en) 2009-04-16
US8835647B2 (en) 2014-09-16
US20150148392A1 (en) 2015-05-28
GT201000080A (es) 2012-04-03
CA2696424C (en) 2018-07-10
CA2696424A1 (en) 2009-04-16
AU2008310781A1 (en) 2009-04-16
RU2476434C2 (ru) 2013-02-27
UA113277C2 (xx) 2017-01-10
JP2017071618A (ja) 2017-04-13
MY156691A (en) 2016-03-15
DOP2010000099A (es) 2017-04-30
JP2014237659A (ja) 2014-12-18
UA101961C2 (xx) 2013-05-27
US20090099245A1 (en) 2009-04-16
BRPI0816221A2 (pt) 2015-06-16
TW200932747A (en) 2009-08-01
KR20100090769A (ko) 2010-08-17
EP2722046A1 (en) 2014-04-23
AU2008310781B2 (en) 2013-03-28
KR20160039312A (ko) 2016-04-08
MX350019B (es) 2016-12-09
CR11368A (es) 2010-10-25
PA8798401A1 (es) 2009-05-15
PH12012501636A1 (en) 2015-07-10
ES2620299T3 (es) 2017-06-28
TWI422588B (zh) 2014-01-11
DK2722046T3 (en) 2017-03-20

Similar Documents

Publication Publication Date Title
CO6280493A2 (es) Forma cristalina 1 de 2-((r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida
EP2331780A4 (en) High security lock
BRPI0819857A2 (pt) Fecho com saliências inibidoras de rotação aperfeiçoadas.
DE602006016404D1 (de) Verschlusssystem mit verbessertem deckelverschluss
DK2262454T3 (da) Halsbeskyttelseskrave med brydbar sikkerhedsstruktur
ATE443668T1 (de) Ziehverschluss mit bidirektionaler verriegelungsanordnung
EP2599401A4 (en) SURFACE CLOSURE WITH OUTSTANDING TEMPORARY FIXING FUNCTION
BRPI1007146A2 (pt) elemento magnético com materiais de camada de armazenamento
NL1036050C (nl) Brandvertragende en brandwerende samenstelling.
AR082804A1 (es) Formas cristalinas de un inhibidor del factor xa
FI20075295A0 (fi) Ovenlukko
ATE501056T1 (de) Fälschungssicherer verschluss
FI20075296A0 (fi) Ovenlukko
EP2345132A4 (en) LIFE SAFETY DEVICE WITH EXTENDED STORAGE TIME
EP2971655A4 (en) LOCKING MECHANISM FOR GONDOLM-ASSEMBLED LOCKING SYSTEM
KR101553709B9 (ko) 반도체 소자 제조용 로드락 챔버와 이를 이용한 반도체 소자의 제조장치
ATE556313T1 (de) Sensor enthaltend formgedächtnismaterialien mit polyelektrolytsegmenten
DE502008002656D1 (de) Schnappverschluss
DE602005010066D1 (de) Behälter mit Garantieverschluss mit blockierter Zunge
ES1072762Y (es) Cerradura con llave
FI20060070A0 (fi) Lukkomutteri
DE502006005317D1 (de) Webschaft mit Selbstspannverschluss
FI8683U1 (fi) Ovenlukon aputelkijärjestely
FR2929978B1 (fr) Serrure a cremone reversible
DE502006000835D1 (de) Phasenregelkreis mit Reduzierter Einschwingzeit

Legal Events

Date Code Title Description
FC Application refused